Eikon Therapeutics Inc
EIKN
NASDAQ
Biotechnology
$11.05
USD
+0.72 (+6.97%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $526.77M
Volume 637.7K
Revenue
—
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
—
TTM
— YoY
Operating Cash Flow
—
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2026 |
|---|---|
Revenue | 0.0 |
YoY Growth | — |
Cost of Revenue | 0.0 |
Gross Profit | 0.0 |
Selling, General & Administrative | 17.3 |
Other Operating Expenses | 0.0 |
Total Operating Expenses | 87.3 |
Operating Income | -87.3 |
EBITDA | -82.1 |
Other Income / Expense | 0.0 |
Total Other Income / Expense | 4.4 |
Income Before Income Taxes | -83.0 |
Income Taxes | 0.0 |
Net Income | -83.0 |
Consolidated Net Income / Loss | -83.0 |
Net Income Attributable to Common Shareholders | -83.0 |
Basic EPS | -$2.46 |
Diluted EPS | -$2.46 |
Basic Shares Outstanding | 33.7M |
Diluted Shares Outstanding | 33.7M |